Review Article Online Published: 09 Dec 2024 | ||||||||||||
IJMDC. 2024; 8(10): 2928-2936 The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis Elshymaa Elsayed Raslan, Abdulaziz Mohammed Alruzaihan, Khaled Saeed Mohammed Alqahtani, Hind Saleh Alyousef, Atef Eid Alrashidi, Malak Mohammed Nehad Alzaeim, Walaa Jehad Alekri, Hawra Habib Khamis, Sereen Saleem Eid Aljohani, Rawabi Saleh Alamri, Yazeed Ibrahim Almershed, Abdullah Khalid Alsaawi, Shahad Anwar Helmi.
|
How to Cite this Article |
Pubmed Style Raslan EE, Alruzaihan AM, Alqahtani KSM, Alyousef HS, Alrashidi AE, Alzaeim MMN, Alekri WJ, Khamis HH, Aljohani SSE, Alamri RS, Almershed YI, Alsaawi AK, Helmi SA. The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. IJMDC. 2024; 8(10): 2928-2936. doi:10.24911/IJMDC.51-1730800498 Web Style Raslan EE, Alruzaihan AM, Alqahtani KSM, Alyousef HS, Alrashidi AE, Alzaeim MMN, Alekri WJ, Khamis HH, Aljohani SSE, Alamri RS, Almershed YI, Alsaawi AK, Helmi SA. The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. https://www.ijmdc.com/?mno=227475 [Access: March 17, 2025]. doi:10.24911/IJMDC.51-1730800498 AMA (American Medical Association) Style Raslan EE, Alruzaihan AM, Alqahtani KSM, Alyousef HS, Alrashidi AE, Alzaeim MMN, Alekri WJ, Khamis HH, Aljohani SSE, Alamri RS, Almershed YI, Alsaawi AK, Helmi SA. The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. IJMDC. 2024; 8(10): 2928-2936. doi:10.24911/IJMDC.51-1730800498 Vancouver/ICMJE Style Raslan EE, Alruzaihan AM, Alqahtani KSM, Alyousef HS, Alrashidi AE, Alzaeim MMN, Alekri WJ, Khamis HH, Aljohani SSE, Alamri RS, Almershed YI, Alsaawi AK, Helmi SA. The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. IJMDC. (2024), [cited March 17, 2025]; 8(10): 2928-2936. doi:10.24911/IJMDC.51-1730800498 Harvard Style Raslan, E. E., Alruzaihan, . A. M., Alqahtani, . K. S. M., Alyousef, . H. S., Alrashidi, . A. E., Alzaeim, . M. M. N., Alekri, . W. J., Khamis, . H. H., Aljohani, . S. S. E., Alamri, . R. S., Almershed, . Y. I., Alsaawi, . A. K. & Helmi, . S. A. (2024) The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. IJMDC, 8 (10), 2928-2936. doi:10.24911/IJMDC.51-1730800498 Turabian Style Raslan, Elshymaa Elsayed, Abdulaziz Mohammed Alruzaihan, Khaled Saeed Mohammed Alqahtani, Hind Saleh Alyousef, Atef Eid Alrashidi, Malak Mohammed Nehad Alzaeim, Walaa Jehad Alekri, Hawra Habib Khamis, Sereen Saleem Eid Aljohani, Rawabi Saleh Alamri, Yazeed Ibrahim Almershed, Abdullah Khalid Alsaawi, and Shahad Anwar Helmi. 2024. The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. International Journal of Medicine in Developing Countries, 8 (10), 2928-2936. doi:10.24911/IJMDC.51-1730800498 Chicago Style Raslan, Elshymaa Elsayed, Abdulaziz Mohammed Alruzaihan, Khaled Saeed Mohammed Alqahtani, Hind Saleh Alyousef, Atef Eid Alrashidi, Malak Mohammed Nehad Alzaeim, Walaa Jehad Alekri, Hawra Habib Khamis, Sereen Saleem Eid Aljohani, Rawabi Saleh Alamri, Yazeed Ibrahim Almershed, Abdullah Khalid Alsaawi, and Shahad Anwar Helmi. "The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis." International Journal of Medicine in Developing Countries 8 (2024), 2928-2936. doi:10.24911/IJMDC.51-1730800498 MLA (The Modern Language Association) Style Raslan, Elshymaa Elsayed, Abdulaziz Mohammed Alruzaihan, Khaled Saeed Mohammed Alqahtani, Hind Saleh Alyousef, Atef Eid Alrashidi, Malak Mohammed Nehad Alzaeim, Walaa Jehad Alekri, Hawra Habib Khamis, Sereen Saleem Eid Aljohani, Rawabi Saleh Alamri, Yazeed Ibrahim Almershed, Abdullah Khalid Alsaawi, and Shahad Anwar Helmi. "The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis." International Journal of Medicine in Developing Countries 8.10 (2024), 2928-2936. Print. doi:10.24911/IJMDC.51-1730800498 APA (American Psychological Association) Style Raslan, E. E., Alruzaihan, . A. M., Alqahtani, . K. S. M., Alyousef, . H. S., Alrashidi, . A. E., Alzaeim, . M. M. N., Alekri, . W. J., Khamis, . H. H., Aljohani, . S. S. E., Alamri, . R. S., Almershed, . Y. I., Alsaawi, . A. K. & Helmi, . S. A. (2024) The efficacy of Sacituzumab Govitecan in treatment of triple-negative breast cancer: a systematic review and meta-analysis. International Journal of Medicine in Developing Countries, 8 (10), 2928-2936. doi:10.24911/IJMDC.51-1730800498 |